Christopher Joseph's questions to Biohaven (BHVN) leadership • Q1 2021
Question
Christopher Joseph of Piper Sandler asked about the sales effort split between primary care and specialists and how the company plans to maintain momentum with PCPs, particularly with the potential addition of a prevention label.
Answer
CEO Vladimir Coric and CCO BJ Jones explained that the strategy involves a natural transition from specialists to primary care, mirroring the acute launch. Jones highlighted the efficiency of the dual-use indication, stating that every promotional dollar will support both acute and preventive messaging, allowing them to maintain focus without a major strategic shift.